Main Menu
Menu

Council for Innovation Promotion

Publish Date
Resources
Infographics
PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB
Council for Innovation Promotion
News
Fake gifts flooding online marketplaces this holiday season. Here’s how to avoid getting scammed.
KTNV-TV
Shakeria Hawkins
Blog
‘Tis the Season — of Counterfeits?

Counterfeiting is a multi-billion-dollar enterprise that puts consumers at serious risk. Poorly-made laptop batteries can overheat. Knock-off cosmetics may contain toxic chemicals....

Council for Innovation Promotion
News
The Patent Eligibility Restoration Act (PERA) Could Provide A Much Needed Boost To Key Technology Sectors Of The U.S. Economy
Mondaq
Stephen P. Scuderi
Press Releases
Council for Innovation Promotion Statement on RALIA and the BIA

WASHINGTON (November 10, 2025) — Recently, Representatives Thomas Massie (R-KY), Marcy Kaptur (D-OH), Michael Cloud (R-TX), Warren Davidson (R-OH), Paul Gosar (R-AZ),...

Council for Innovation Promotion
Blog
This Month in IP: October 2025

Strong, consistent IP protections throughout U.S. history enabled the creation of innovative and useful technologies that we use regularly today. From firefighting...

Council for Innovation Promotion
Blog
C4IP Coalition Updates: October 2025

October Highlights: C4IP Advocates for the Patent Eligibility Restoration Act On October 8, the Senate Judiciary Subcommittee on Intellectual Property held a...

Council for Innovation Promotion
News
C4IP Urges USTR to Use USMCA Joint Review to Address Shortcomings on IP Protections
IPWatchdog
Steve Brachmann
Resources
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Council for Innovation Promotion
Resources
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
Council for Innovation Promotion
Blog
Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth

The FDA recently approved a new version of Keytruda, a cancer immunotherapy medicine that is one of the world’s most successful drugs....

Council for Innovation Promotion
BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Council for Innovation Promotion
Resources:

Resources:

PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB,

11/17/2025
News:

News:

Fake gifts flooding online marketplaces this holiday season. Here’s how to avoid getting scammed.,

11/17/2025
Blog:

Blog:

‘Tis the Season — of Counterfeits?,

11/14/2025
News:

News:

The Patent Eligibility Restoration Act (PERA) Could Provide A Much Needed Boost To Key Technology Sectors Of The U.S. Economy,

11/13/2025
Press Releases:

Press Releases:

Council for Innovation Promotion Statement on RALIA and the BIA,

11/10/2025
Blog:

Blog:

This Month in IP: October 2025,

11/10/2025
Blog:

Blog:

C4IP Coalition Updates: October 2025,

11/10/2025
News:

News:

C4IP Urges USTR to Use USMCA Joint Review to Address Shortcomings on IP Protections,

11/07/2025
Resources:

Resources:

C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime,

11/06/2025
Resources:

Resources:

C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004),

11/03/2025
Blog:

Blog:

Why Continued Innovation Matters: Keytruda and the “Product Hopping” Myth,

11/03/2025
Blog:

Blog, Fact Checks:

Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards,

10/30/2025
Scroll to Top